The accompanying condensed consolidated financial statements have been prepared by CTS Corporation (“CTS” "we", "our", "us" or the "Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to such rules and regulations.
The results of operations for the interim periods are not necessarily indicative of the results for the entire year.
We usually expect payment within 30 to 90 days from the shipping date, depending on our terms with the customer.
invoiced, collected from, or paid to our customers are recognized as contract assets or liabilities.
Contract assets will be reviewed for impairment when events or circumstances indicate that they may not be recoverable.
The increase in contract liabilities as of September 30, 2018 is primarily due to net increases in estimated future discounts and price concessions, offset by net settlements of products sold with rights of return.
(1) Expected return on plan assets is net of expected investment expenses and certain administrative expenses.
In June 2016, we announced plans to restructure operations by phasing out production at our Elkhart facility by the end of 2018 and transitioning it into a research and development center supporting our global operations ("June 2016 Plan").
Additional organizational changes were also implemented in various other locations.Sales were $118,859 in the third quarter of 2018, an increase of $12,616 or 11.9% from the third quarter of 2017.
Sales to transportation markets increased $6,613 or 9.6%.
Other sales increased $6,003 or 15.9%.
The improvement from savings related to product line transfers was partially offset by tariff and material cost increases.
Interest expense decreased mainly as a result of the reduction in debt year-over-year.
Other expense in the third quarter of 2018 was principally driven by foreign currency translation losses, mainly due to the appreciation of the U.S. Dollar compared to the Chinese Renminbi during the quarter.
Research and development expenses were $19,500 or 5.6% of sales in the nine months ended September 30, 2018 compared to $18,432 or 5.9% of sales in the comparable prior year period.
The loss on sale of assets in 2017 was driven by the sale of vacant land adjacent to our Hopkinton, Massachusetts facility.